Pier Capital’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8K Sell
54
-2,919
-98% -$639K ﹤0.01% 105
2025
Q1
$666K Buy
2,973
+420
+16% +$94K 0.11% 96
2024
Q4
$836K Buy
2,553
+440
+21% +$144K 0.12% 90
2024
Q3
$634K Buy
2,113
+471
+29% +$141K 0.09% 108
2024
Q2
$541K Buy
1,642
+53
+3% +$17.5K 0.08% 108
2024
Q1
$629K Buy
1,589
+22
+1% +$8.71K 0.09% 107
2023
Q4
$552K Buy
1,567
+528
+51% +$186K 0.08% 105
2023
Q3
$390K Sell
1,039
-22
-2% -$8.26K 0.06% 104
2023
Q2
$406K Buy
+1,061
New +$406K 0.06% 105
2019
Q2
Sell
-84,506
Closed -$9.31M 116
2019
Q1
$9.31M Buy
84,506
+54,946
+186% +$6.06M 1.44% 4
2018
Q4
$2.9M Sell
29,560
-41,993
-59% -$4.12M 0.58% 89
2018
Q3
$8.84M Buy
71,553
+1,217
+2% +$150K 1.11% 32
2018
Q2
$6.98M Buy
70,336
+8,676
+14% +$861K 0.96% 69
2018
Q1
$5.44M Buy
61,660
+937
+2% +$82.7K 0.93% 72
2017
Q4
$5.99M Sell
60,723
-1,059
-2% -$105K 1.02% 39
2017
Q3
$5.95M Buy
61,782
+917
+2% +$88.3K 1.03% 44
2017
Q2
$5.75M Sell
60,865
-3,536
-5% -$334K 0.99% 52
2017
Q1
$5.26M Sell
64,401
-583
-0.9% -$47.6K 0.9% 75
2016
Q4
$5.51M Sell
64,984
-1,944
-3% -$165K 1% 51
2016
Q3
$4.99M Sell
66,928
-35,154
-34% -$2.62M 0.88% 81
2016
Q2
$7.75M Sell
102,082
-3,351
-3% -$254K 1.41% 5
2016
Q1
$7.31M Sell
105,433
-12,380
-11% -$858K 1.41% 5
2015
Q4
$7.1M Sell
117,813
-2,396
-2% -$144K 1.23% 18
2015
Q3
$6.51M Buy
120,209
+2,804
+2% +$152K 1.06% 33
2015
Q2
$6.82M Sell
117,405
-5,235
-4% -$304K 0.98% 54
2015
Q1
$7.38M Buy
+122,640
New +$7.38M 1.11% 26